Literature DB >> 29942758

Pulmonary artery intravascular abscess: A rare complication of incomplete infective endocarditis treatment in the setting of injection drug use.

Simran Gupta1, David B Banach1,2, Lisa M Chirch1,2.   

Abstract

Infective endocarditis (IE) is a serious complication of injection drug use. Right-sided IE encompasses 5-10% of all IE cases, with the majority involving the tricuspid valve (TV). The predominant causal organism is Staphylococcus aureus. Most cases of right-sided IE can be successfully treated with antimicrobials, but approximately 5-16% require eventual surgical intervention. We report the case of a 36-year-old female with active injection drug use who developed methicillin-sensitive Staphylococcus aureus IE of the tricuspid valve. Associated with poor adherence to medical therapy as a consequence of opioid addiction, she developed septic emboli to the lungs and an intravascular abscess in the left main pulmonary artery. These long-term potentially fatal, sequelae of incompletely treated IE require surgical intervention, as medical therapy is unlikely to be sufficient. Surgical management may involve TV replacement, pulmonary artery resection, and pneumonectomy. Prevention of these complications may have been achieved by concurrent opioid addiction therapy. An intravascular pulmonary artery abscess is a novel complication of advanced IE that has not been previously reported. This complication likely arose due to incomplete IE treatment as a consequence of opioid addiction, highlighting the need for concurrent addiction management. Intravenous antimicrobial therapy is likely not adequate, and surgical intervention, including pulmonary artery resection and pneumonectomy may be necessary.

Entities:  

Keywords:  Infective endocarditis; Injection drug use; Opioid use disorder; Pulmonary artery abscess

Year:  2018        PMID: 29942758      PMCID: PMC6010969          DOI: 10.1016/j.idcr.2018.03.019

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Introduction

Tricuspid valve infective endocarditis (TVIE) is a serious complication of injection drug use (IDU) with a mortality rate of 10–15% and potential for further deadly complications [[1], [2], [3]]. Staphylococcus aureus accounts for 60–90% of cases of TVIE, with enterococci, streptococci, Pseudomonas, and HACEK organisms occurring less frequently [1,2,4]. Most cases of TVIE are treated medically, with only approximately 4% of all IE surgeries in North America for TVIE [5]. Surgical treatment is indicated in cases of persistent and refractory infection with difficult to eradicate organisms i.e. fungi [1,4]. Additionally, large valve vegetations and persistent septic pulmonary emboli are indications for operative management [1]. We report the case of a patient with a history of active IDU who developed methicillin-sensitive Staphylococcus aureus (MSSA) TVIE and Candida fungemia. After numerous unsuccessful attempts to complete medical therapy, she developed septic pulmonary emboli, proximal lung abscesses, and an abscess in the left main pulmonary artery. We highlight the importance of concurrent treatment of opioid addiction with intravenous antimicrobial therapy in patients with IDU and deep-seated infections to prevent long term complications, and review the literature to understand potential surgical treatment of such sequelae.

Case presentation

A 36-year-old Caucasian female with a history of active IV heroin use, anxiety, and depression presented to the emergency department (ED) with one week of chest pain and shortness of breath. A trans-thoracic echocardiogram revealed a 13 × 26 mm vegetation of the tricuspid valve (TV) with moderate tricuspid regurgitation. She was treated with IV vancomycin and cefepime, however left the hospital against medical advice (AMA) after one day, feeling that her pain was poorly controlled. She returned to the ED within 24 hour s with dyspnea and a productive cough. Chest x-ray revealed a right middle lobe infiltrate. Blood cultures grew MSSA (Fig. 1), and she was admitted to the ICU and treated with oxacillin. She completed one day of therapy, once again leaving AMA. She returned to the hospital the following day with severe dyspnea. Imaging revealed new septic emboli in the lung fields (Fig. 2). The patient was admitted and completed an eight day course of oxacillin and was discharged to a skilled nursing facility (SNF) with a peripherally inserted central catheter (PICC) line for continued medical treatment with oxacillin. She eloped from the SNF after 12 days.
Fig. 1

MICs for blood cultures growing methicillin-sensitive Staphylococcus aureus.

Fig. 2

CT chest with IV contrast revealing new septic emboli in the lung fields.

MICs for blood cultures growing methicillin-sensitive Staphylococcus aureus. CT chest with IV contrast revealing new septic emboli in the lung fields. Three weeks later, she presented to an outpatient appointment with confusion and weakness. Blood cultures grew Candida famata, and the patient was urged to report to the ED for treatment. She was given one dose of caspofungin in the ED before leaving AMA. Blood cultures drawn prior to administration of caspofungin subsequently grew Candida parapsilosis, and the patient was again advised to return to the ED. She was hospitalized and treated with oxacillin and fluconazole and developed substernal chest pain. Blood cultures remained positive for MSSA throughout the hospital course, with no further growth of Candida. Repeat chest x-ray during this admission showed multifocal airspace opacities and continued cavitary lesions in the lung fields. She left AMA after seven days due to persistent and inadequately controlled symptoms of opioid withdrawal. One week later she returned to the ED in septic shock. She was administered IV fluids, vancomycin, caspofungin, and ceftriaxone in the ED and admitted to the hospital where she began to complain of pleuritic chest pain. CT of the chest with IV contrast demonstrated multiple new solid cavitary lesions bilaterally, a left sided loculated effusion, and a 1.8 cm diameter fluid attenuation within the left perihilar lung surrounding a consolidation, suspicious for a septic intravascular pulmonary embolism with abscess formation in the left main pulmonary artery (Fig. 3). Imaging strongly indicated that the abscess was likely not within the wall of the pulmonary artery, but intraluminal, with inflammation of the artery wall. Although the artery did appear dilated on CT, there did not appear to be any pseudoaneurysms. Trans-esophageal echocardiogram revealed a 1.9 × 1.5 × 1.5 cm diameter multi-lobulated, highly mobile vegetation on the anterior leaflet of the TV with severe regurgitation and possible leaflet perforation.
Fig. 3

A–C: CT chest with IV contrast revealing multiple new solid cavitary lesions bilaterally, C: left sided loculated effusion and D. 1.8 cm fluid attenuation within the left perihilar lung surrounding a consolidation, suspicious for a septic intravascular pulmonary embolism with abscess formation in the left main pulmonary artery. Fluid attenuation occludes in the distal left main pulmonary artery at its bifurcation with no contrast seen in the lower lobe pulmonary arteries. Associated pulmonary infarcts involving the majority of the left lower lobe and posterior upper lobe.

A–C: CT chest with IV contrast revealing multiple new solid cavitary lesions bilaterally, C: left sided loculated effusion and D. 1.8 cm fluid attenuation within the left perihilar lung surrounding a consolidation, suspicious for a septic intravascular pulmonary embolism with abscess formation in the left main pulmonary artery. Fluid attenuation occludes in the distal left main pulmonary artery at its bifurcation with no contrast seen in the lower lobe pulmonary arteries. Associated pulmonary infarcts involving the majority of the left lower lobe and posterior upper lobe. Cardiothoracic surgery was eventually consulted for potential surgical intervention, but the patient was considered a poor surgical candidate due to her continued hemodynamic instability and history of non-compliance to therapy. A repeat chest CT was obtained which showed proximal right-sided lung abscesses and findings suspicious for additional emboli in the segmental and subsegmental arteries of the right lower lobe. She was discharged to a subacute nursing facility for six weeks of treatment with cefazolin. Blood cultures remained negative for two weeks prior to discharge. The patient completed her six-week antibacterial course with one relapse of heroin use. Repeat imaging after completion of therapy demonstrated a large highly mobile vegetation of the tricuspid valve, unchanged in size from previous studies, with continued severe tricuspid regurgitation.

Discussion

To our knowledge this is the first reported case of an abscess in the left main pulmonary artery as a complication of IE. The development of this abscess demonstrates the importance of completion of intravenous antimicrobial therapy and the necessity of addiction management in promoting patient adherence with intravenous antimicrobial therapy. This patient repeatedly withdrew from medical therapy due to her heroin addiction and thus developed serious and life threatening complications of IE including TV perforation, septic emboli, and an arterial abscess. TV repair/replacement is a well-studied treatment option for IE with the patient meeting criteria for stage D tricuspid regurgitation (symptomatic, severe TR) and published indications for TV surgery [6]. Studies have shown better peri-operative and event free survival with TV repair as compared to replacement [1,8]. Indications for replacement include significant leaflet tethering, distortion of the valve, ventricular dysfunction, or severe pulmonary hypertension. This patient, with possible TV leaflet perforation, was likely more suitable for TV replacement [1,7,8]. Additionally, practice guidelines state that patients with right sided IE are indicated for surgical intervention in cases of lack of response to antimicrobial therapy, sustained infection with difficult to treat organisms including fungi and multidrug resistant bacteria, TV vegetations >20 mm, and recurrent pulmonary emboli despite antimicrobial therapy [1,9]. However, guidelines also suggest that it may be reasonable to avoid surgery in right sided IE in patients with a history of IDU [9]. Septic emboli occur in approximately 13–44 percent of patients with IE [10]. Treatment of septic emboli involves underlying infection/source control in combination with antimicrobial therapy [1,11]. Complications of septic emboli include mycotic pulmonary aneurysms treated with coil embolization, vascular obstruction treated with thrombectomy, and abscess/infarct of the lung lobes treated with surgical drainage and/or resection of the infarcted area [[10], [11], [12], [13]]. Intravascular abscesses have not been previously reported as a complication of IE. At this point, medical therapy is unlikely to be sufficient, and surgical treatment may be optimal. A related report studying infiltrative, non-small cell lung cancer has shown that resection and repair of the pulmonary artery followed by pneumonectomy using a temporary intra-arterial conduit technique is both feasible and safe, with acceptable post-operative morbidity rates (complication rates of 52.2% and 5-yr survival of 50%) [14]. This surgical technique has not been studied in patients with advanced IE, but has potential for application to this case. Surgical interventions were not pursued in this case due to the patient’s history of non-adherence to medical therapy. The patient’s disease course, complicated by continued heroin use at home and even in the hospital on two occasions, underscores the struggle of drug addiction. Appropriate opioid addiction treatment may likely have facilitated adherence to and completion of a long-term intravenous antimicrobial regimen, preventing the development of catastrophic complications of her disease. Opioid use disorder can successfully be managed during and after acute hospitalizations with methadone, and treatment can help facilitate other inpatient care [15]. An initial dose of 20–30 mg daily can safely be started inpatient, and providers should encourage a long-term treatment plan and arrange for transfer to a maintenance program after discharge. If methadone cannot be initiated due to underlying disease or concern for interaction with CYP-450 inducers such as antiretrovirals, buprenorphine, a partial opioid agonist, can be used to manage acute withdrawal symptoms, and can be continued outpatient [15]. Initiation of methadone therapy during our patient’s first hospital admission may have prevented her prolonged disease course.

Conclusion

The presented case demonstrates a novel and rare complication of infective endocarditis. The development of the pulmonary artery abscess was likely due to poor adherence to medical therapy, highlighting the importance of completion of antimicrobial treatment. The patient’s inability to complete medical therapy, however, was likely a consequence of her heroin addiction, emphasizing the necessity for concurrent opioid addiction treatment. The current opioid crisis in the United States was recently named a public health emergency [16], and this case highlights the urgent need for effective and long term addiction management strategies to ensure compliance to medical therapy – including outpatient parenteral antimicrobial therapy – and prevention of potentially fatal long-term sequelae.

Funding

The author(s) received no funding for the authorship and/or publication of this article.

Patient consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Declaration of conflicting interests

The author(s) have declare no potential conflicts of interest with respect to authorship and/or publication of this article.
  14 in total

Review 1.  Multiple pulmonary artery pseudoaneurysms: intrasaccular embolization.

Authors:  B Ghaye; G Trotteur; R F Dondelinger
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

2.  Tricuspid valve endocarditis.

Authors:  Syed T Hussain; James Witten; Nabin K Shrestha; Eugene H Blackstone; Gösta B Pettersson
Journal:  Ann Cardiothorac Surg       Date:  2017-05

Review 3.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

4.  Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair?

Authors:  Gilles D Dreyfus; Pierre J Corbi; K M John Chan; Toufan Bahrami
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

5.  Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings.

Authors:  Amanda Noska; Aron Mohan; Sarah Wakeman; Josiah Rich; Amy Boutwell
Journal:  J Addict Behav Ther Rehabil       Date:  2015

6.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Authors:  David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell
Journal:  Arch Intern Med       Date:  2009-03-09

7.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

8.  Current outcomes for tricuspid valve infective endocarditis surgery in North America.

Authors:  Jeffrey G Gaca; Shubin Sheng; Mani Daneshmand; J Scott Rankin; Matthew L Williams; Sean M O'Brien; James S Gammie
Journal:  Ann Thorac Surg       Date:  2013-08-20       Impact factor: 4.330

9.  Acute endocarditis in intravenous drug users: a case report and literature review.

Authors:  Yan Ji; Lara Kujtan; Dawn Kershner
Journal:  J Community Hosp Intern Med Perspect       Date:  2012-04-30

10.  Surgical techniques and results of the pulmonary artery reconstruction for patients with central non-small cell lung cancer.

Authors:  Qianli Ma; Deruo Liu; Yongqing Guo; Bin Shi; Yanchu Tian; Zhiyi Song; Zhenrong Zhang; Bingsheng Ge; Xiaofei Wang; Thomas A D'Amico
Journal:  J Cardiothorac Surg       Date:  2013-12-01       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.